Fundraising FoxAnchordx
Guangzhou, CN · 3 known investors
Find your way into Anchordx
Sign up to see every warm intro you have to Anchordx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Anchordx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.
Founders & leadership
Investors · 3
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Anchordx do?
- AnchorDx develops, manufactures, and sells cancer early-screening and diagnostic products based on ctDNA methylation high-throughput sequencing, along with related testing services covering over 70% of high-incidence cancers such as lung, breast, digestive, and urinary cancers. Founded in 2015 in Guangzhou, China with R&D centers in China and the US, it also runs a big-data and AI platform focused on lung cancer detection and treatment.
- Who founded Anchordx?
- Anchordx was founded by 范建兵.
- Who are Anchordx's investors?
- Anchordx's investors include Marathon Venture Partners, OrbiMed, 6 Dimensions Capital.
- Where is Anchordx headquartered?
- Anchordx is headquartered in Guangzhou, CN.